Page last updated: 2024-11-05

1,3-cyclohexadiene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3-cyclohexadiene: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11605
CHEBI ID37610
MeSH IDM0105106

Synonyms (35)

Synonym
jv5w0eg5bp ,
unii-jv5w0eg5bp
einecs 209-764-1
1,3-cyclohexadiene
inchi=1/c6h8/c1-2-4-6-5-3-1/h1-4h,5-6h
cyclohexadiene-1,3
cyclohexa-1,3-diene
592-57-4
1,2-dihydrobenzene
CHEBI:37610
1,3-cyclohexadiene, contains 0.05% bht as inhibitor, 97%
cyclohexadiene
A832226
AKOS009119921
7y6a5b2t62 ,
29797-09-9
unii-7y6a5b2t62
einecs 249-853-2
STL281378
FT-0606596
AM806998
benzene, dihydro-
2,4-cyclohexadiene
1,3 cyclohexadiene
1,3-cyclo hexadiene
1,3-cyclohexanediene
1,-3-cyclohexadiene
STR07880
mfcd00001532
F17012
DTXSID30862259
Q387320
cyclohexa-1
1165952-91-9
EN300-27318
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cyclohexadiene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (42)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (14.29)18.7374
1990's0 (0.00)18.2507
2000's11 (26.19)29.6817
2010's23 (54.76)24.3611
2020's2 (4.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.14 (24.57)
Research Supply Index3.78 (2.92)
Research Growth Index5.59 (4.65)
Search Engine Demand Index69.65 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]